Please login to the form below

Not currently logged in
Email:
Password:

Orphacol

This page shows the latest Orphacol news and features for those working in and with pharma, biotech and healthcare.

EC sets up expert group on rare diseases

EC sets up expert group on rare diseases

approve a previously-rejected drug - CTRS' Orphacol - earlier this month.

Latest news

  • Court orders EC to approve rejected orphan medicine Court orders EC to approve rejected orphan medicine

    Court orders EC to approve rejected orphan medicine. Says CTRS should be allowed to market Orphacol for the treatment of rare bile condition. ... The battle pitched small French pharma company Cell Therapies Research & Services (CTRS) against the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics